Cannabis Has Record-Setting
Month
March 5, 2019 -- InvestorsHub NewsWire -- Microcap Speculators
-- The cannabis industry continues to make large strides.
Last year, Canada became the first industrialized country in the
world to legalize recreational weed. Two-thirds of U.S. states have
approved marijuana in some capacity with 66% of respondents polled
in Gallup's October 2018 survey favoring the idea of legalizing
marijuana.
Cannabis investors continue to show favor to this growth.
Last month, 15 pot stocks rallied by at least 50% with many of
the largest marijuana stocks up by a high-triple-digit or
quadruple-digit percentage since 2016 began.
Looking for stocks that may receive a boost from investors in
this industry, CleanSpark, Inc. (USOTC:
CLSK) and their microgrid power solution for the
cannabis industry that cuts the monthly electricity bill of indoor
grow-houses by up to 82%, may be a good option to research.
The company is not fully exposed to cannabis, as most of their
revenue is driven from operations unrelated to cannabis. The
company has been ranked in the top 10 microgrids by Navigant
Research.
Today we are highlighting: CleanSpark, Inc. (USOTC:
CLSK), GW Pharmaceuticals plc (NASDAQ:
GWPH), HEXO Corp. (HEXO), CannTrust Holdings, Inc. (NYSE:
CTST), and Canopy Growth Corporation (NYSE:
CGC).
It’s been a busy few months for CleanSpark, Inc.
(USOTC:
CLSK) (Market Cap: $173.016M, Share Price:
$4.17) has announced an up to $18 million deal with
NYSE company MAC, which has completed an acquisition adding $3.6
million in gross sales to CLSK’s bottom line during early 2019
alone and several other achievements that have brought this
microgrid growth play well off its $1.10 52-week low.
The company counts itself as one of the very few OTC companies
on the LD Micro Index (only 4% of the 1000 companies are OTC
listed). The increase in exposure means investors should
research CLSK now.
______
GW Pharmaceuticals plc (NASDAQ:
GWPH) (Market Cap: $5.707B, Share Price:
$176.43) reported impressive numbers highlighted by
its strong launch for cannabinoid oil Epidiolex in seizure
treatment. Epidiolex generated $4.7 million in sales over two
months.
_______
HEXO Corp. (HEXO) (Market Cap:
$1.141B, Share Price: $5.55) is forming a
joint venture with Molson Coors. The company is partnering with
HEXO, which'll likely be a top-10 producer by peak annual output
Molson Coors gets its foot in the door in a fast-growing industry,
while giving HEXO the marketing leadership it needs.
_______
CannTrust Holdings, Inc. (NYSE:
CTST) (Market Cap: $995M, Share Price:
$9.02), a Canada-based cannabis producer, has just
added itself to the list of Canadian producers to list on the
NYSE. Further legitimizing an industry that was taboo only a
few years ago.
________
Canopy Growth Corporation (NYSE:
CGC) (Market Cap: $15.918B, Share Price:
$46.80) announced earlier this week that it has named
Hilary Black as its Chief Advocacy Officer, effective
immediately. In her expanded role, Hilary's mandate includes
driving patient advocacy efforts worldwide, executing the company's
global corporate social responsibility strategy and leading the
implementation of best practices for diversity & inclusion.
Legal Disclaimer:
This article was written by Regal Consulting, LLC (“Regal
Consulting”). Regal Consulting has agreed to a three-month
term consulting agreement with CLSK dated 9/12/18. The
agreement calls for $10,000 in cash, and 30,000 restricted 144
shares of CLSK per month. Regal and CLSK have signed an amendment
to extend the contract for twelve months starting 10/10/18, and
increased the cash component to $20,000 per month. CLSK has
paid an additional $12,000 for services provided in November. CLSK
has paid an additional $88,000 for services provided in December.
CLSK has paid an additional $100,000 for services for
January. CLSK has paid an additional $80,000 for services for
February. Regal was paid an additional $30,000 for March services
and possibly compensated more for March in the future, at which
time Regal will update this disclaimer. All payments were made
directly by Clean Spark, Inc. to Regal Consulting, LLC. to provide
investor relations services, of which this article is a part of.
Regal Consulting also paid one thousand dollars cash to
microcapspeculators.com to distribute this article. Regal
Consulting may have a position in the securities mentioned in this
article at the time of publication, and may increase or decrease
its position without notice. This article is based on public
information and the opinions of Regal Consulting. CLSK was given an
opportunity to edit this article. This article contains
forward-looking statements that are subject to certain risks and
uncertainties that could cause actual results to differ materially
from any results predicted herein. Regal Consulting is not
registered with any financial or securities regulatory authority,
and does not provide or claim to provide investment advice.
http://www.regalconsultingllc.com/full
legal disclaimer/
Microspeculators.com Full Legal Disclaimer Click Here.
Contact Information:
Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspeculators.com
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Sep 2023 to Sep 2024